(Q37993754)

26 August 2017

0 references

Systematic review and meta-analysis of the efficacy of cardioversion by vernakalant and comparators in patients with atrial fibrillation (English)

1 reference

26 August 2017

0 references

1 reference

1 reference

1 reference

8

Mkaya Mwamburi

1 reference

26 August 2017

5

Kyle Fahrbach

1 reference

26 August 2017

4

Amber Martin

1 reference

26 August 2017

Lori D Bash

1

1 reference

26 August 2017

Jessica L Buono

2

1 reference

26 August 2017

Glenn M Davies

3

1 reference

26 August 2017

Hemant Phatak

6

1 reference

26 August 2017

Ruzan Avetisyan

7

1 reference

26 August 2017

1 April 2012

1 reference

Cardiovascular Drugs and Therapy

26 August 2017

1 reference

26 August 2017

26

1 reference

26 August 2017

2

1 reference

26 August 2017

167-179

1 reference

Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew/Paisley study

26 August 2017

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Costs of atrial fibrillation in five European countries: results from the Euro Heart Survey on atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Delayed rhythm control of atrial fibrillation may be a cause of failure to prevent recurrences: reasons for change to active antiarrhythmic treatment at the time of the first detected episode

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Is rhythm control superior to rate control in patients with atrial fibrillation and congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Rate control vs rhythm control in patients with nonvalvular persistent atrial fibrillation: the results of the Polish How to Treat Chronic Atrial Fibrillation (HOT CAFE) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

The cost comparison of rhythm and rate control strategies in persistent atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Rhythm control versus rate control for atrial fibrillation and heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Comparison of rate and rhythm control in hypertension patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

New developments in atrial antiarrhythmic drug therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Pathophysiology and disease progression of atrial fibrillation: importance of achieving and maintaining sinus rhythm

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Atrial fibrillation-the final frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Limitations to antiarrhythmic drug use in patients with atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Can we improve outcomes in AF patients by early therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

New antiarrhythmic drugs for establishing sinus rhythm in atrial fibrillation: what are our therapies likely to be by 2010 and beyond?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Risks and benefits of antiarrhythmic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Novel approaches for pharmacological management of atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Vernakalant (RSD1235): a novel, atrial-selective antifibrillatory agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Simultaneous comparison of multiple treatments: combining direct and indirect evidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Systematic reviews: synthesis of best evidence for clinical decisions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

A randomized active-controlled study comparing the efficacy and safety of vernakalant to amiodarone in recent-onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Comparison between propafenone and digoxin administered intravenously to patients with acute atrial fibrillation. PAFIT-3 Investigators. The Propafenone in Atrial Fibrillation Italian Trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Vernakalant hydrochloride for rapid conversion of atrial fibrillation: a phase 3, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Periprocedural thromboprophylaxis in patients receiving chronic anticoagulation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Effects of a high dose intravenous bolus amiodarone in patients with atrial fibrillation and a rapid ventricular rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Incorporating direct and indirect evidence using bayesian methods: an applied case study in ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Predictors and prognosis of paroxysmal atrial fibrillation in general practice in the UK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Conversion of recent onset atrial fibrillation to sinus rhythm using a single oral loading dose of propafenone: comparison of two regimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Randomized, crossover, controlled comparison of oral loading versus intravenous infusion of propafenone in recent-onset atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Intravenous propafenone for converting recent onset atrial fibrillation in emergency departments: a randomized placebo-controlled multicenter trial. FAPS Investigators Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Flecainide versus ibutilide for immediate cardioversion of atrial fibrillation of recent onset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Intravenous diltiazem is superior to intravenous amiodarone or digoxin for achieving ventricular rate control in patients with acute uncomplicated atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Pharmacological therapy for atrial fibrillation: current options and new agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

A randomized, controlled trial of RSD1235, a novel anti-arrhythmic agent, in the treatment of recent onset atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Conversion of recent onset paroxysmal atrial fibrillation to normal sinus rhythm: the effect of no treatment and high-dose amiodarone. A randomized, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Effectiveness of loading oral flecainide for converting recent-onset atrial fibrillation to sinus rhythm in patients without organic heart disease or with only systemic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

Conversion of recent-onset atrial fibrillation by a single oral loading dose of propafenone or flecainide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10557-012-6374-4

10.1007/S10557-012-6374-4

21 January 2018

Identifiers

DOI

1 reference

26 August 2017

1 reference